PRKDC and neoplasm: These results were confirmed in vivo following intravenous injections which showed the ability of the chemically A10-3-siRNA chimeras to knockdown specifically DNA-PK in subcutaneous PSMA-positive tumours when compared with aptamer chimeras incubated in the presence of PSMA-negative tumours.